8-KRegulation FDExhibits & Filings

INTEL CORP 8-K Report, Regulation FD Disclosure (Dec 30, 2021)

Filed December 30, 2021For Securities:INTC

Summary

Intel Corporation (INTC) has filed an 8-K report on December 29, 2021, to announce the first closing of its previously disclosed agreement with SK hynix Inc. to sell Intel's NAND memory and storage business. This initial closing involves the transfer of Intel's NAND fabrication facility in Dalian, China, along with related assets and Intel's NAND solid-state drive business to SK hynix. The transaction is a significant divestiture for Intel as it continues to reshape its business portfolio. Investors should note that this is only the first of two closings, with the second closing concerning Intel's NAND memory technology and manufacturing business yet to occur. The announcement serves as a Regulation FD disclosure and provides an update on the progress of this strategic transaction. While specific financial terms of the first closing are not detailed in this filing, it indicates forward movement on Intel's plan to exit the NAND business. The company has also included standard forward-looking statements and risk factors, highlighting potential delays or challenges related to the second closing and the overall transaction, including governmental approvals and integration.

Key Highlights

  • 1Intel Corporation announced the first closing of its agreement with SK hynix Inc. to sell its NAND memory and storage business, effective December 29, 2021.
  • 2The first closing includes the transfer of Intel's NAND fabrication facility in Dalian, China, and its NAND solid-state drive business to SK hynix.
  • 3This divestiture is part of Intel's ongoing strategy to reposition its business portfolio and focus on core areas.
  • 4The transaction is structured in two closings; this report details the completion of the first closing only.
  • 5The second closing, pertaining to Intel's NAND memory technology and manufacturing business, is still pending.
  • 6The filing includes forward-looking statements and highlights various risks and uncertainties that could impact the completion and benefits of the transaction, such as regulatory approvals and potential delays.

Frequently Asked Questions